Pharmaceutical and biotechnology companies developing new antimicrobial therapeutics and diagnostic devices are eligible for consideration of membership in AWG.
All AWG members must have:
- At least one antimicrobial drug in preclinical or clinical development, or engagement in diagnostic device development linked to AMR
- A strong commitment to dialogue with relevant stakeholders (including federal agencies, legislators, payors, physicians, patients, and public health officials) to improve the environment for antimicrobials and diagnostic device development
If you are interested in learning more about becoming a member of AWG, please contact us!